Acute respiratory viral infection
Not recommended
Sodium deoxyribonucleate (Derinat) is marketed as an immunomodulator for treating and preventing acute respiratory viral infections. No convincing benefit has been shown for this use: there is no solid evidence base for it in respiratory viral infections. These infections usually clear on their own within a few days, and what actually helps is supportive care – rest, fluids, and symptom relief when needed. The substance is harmless in this role, but it should not replace an approach with proven benefit, since that risks missing the treatment a person needs.